Rigrodsky & Long, P.A. announces that a complaint has been filed in the United States District Court for the Middle District of Florida on behalf of all persons or entities that purchased the securities of Body Central Corporation (“Body Central” or the “Company”) (NASDAQ GS: BODY) between November 10, 2011 and June 18, 2012, inclusive (the “Class Period”), alleging violations of the Securities Exchange Act of 1934 against the Company and certain of its officers and directors (the “Complaint”).
If you purchased shares of Body Central during the Class Period and wish to discuss this action or have any questions concerning this notice or your rights or interests, please contact Timothy J. MacFall, Esquire or Peter Allocco of Rigrodsky & Long, P.A., 825 East Gate Boulevard, Suite 300, Garden City, NY at (888) 969-4242, by e-mail to firstname.lastname@example.org, or at: http://www.rigrodskylong.com/investigations/body-central-corporation-body.
Body Central, a Delaware corporation headquartered in Jacksonville, Florida, is a multi-channel specialty retailer offering on-trend, quality apparel and accessories at value prices. The Complaint alleges that throughout the Class Period, defendants made materially false and misleading statements regarding the Company’s business operations, financial condition and prospects. Specifically, the Complaint alleges (1) that the Company’s merchandise miss was not an isolated, quickly fixable event, but would take at least several quarters to remedy and would have a material, negative impact on the Company’s financial results; (2) that the Company’s stores were experiencing increasingly poor performance and financial results; (3) that the Defendants issued materially false and misleading statements regarding the Company’s operations and its business and financial results and outlook; and (4) that based on the above, Defendants lacked a reasonable basis for their positive statements about the Company or its revenue outlook. As a result of defendants’ false and misleading statements, the Company’s stock traded at artificially inflated prices during the Class Period.